Amid a broad push for affordable and accessible care, the life sciences industry is focusing on the patient as the core of its business strategies. A key element: hospitals, drug makers and medical devices firms are increasingly using technologies such as mobility, digital channels, wearable sensors and data analytics to improve outcomes for patients. Sangita Singh, who heads Wipro Technologies’ health care and life sciences business unit, and Patricia Danzon, a Wharton professor of health care management, discuss the advances in patient centricity in this Future of Industry series white paper, produced by Knowledge at Wharton and sponsored by Wipro.

Comments

New This Week

Greenhushing: When Firms Do More Than They Say

Greenhushing: When Firms Do More Than They Say

September 8, 20265 min read

Some companies downplay their environmental efforts, a practice known as greenhushing. A new working paper co-authored by Wharton’s Serguei Netessine finds that this gap between what firms say and what they do is associated with higher subsequent abnormal stock returns.

AI Is Producing More Software. Why Isn’t It Being Used?

AI Is Producing More Software. Why Isn’t It Being Used?

September 8, 20264 min read

A Wharton study finds that while AI dramatically speeds up software development, human bottlenecks prevent many of those gains from reaching customers.

The Hidden Financial Risks of the AI Boom
Podcast

The Hidden Financial Risks of the AI Boom

September 4, 202613 min listen

Joao Gomes, Wharton professor of finance and senior vice dean of research, centers, and academic initiatives, explains why the Federal Reserve needs to pay closer attention to how the massive AI boom is being financed.